Localized Prostate Cancer: Early Intervention or Expectant Therapy?

Quinn M. Radical prostate cancer surgery quadruples. Lancet 1996; 348: 48.

Johansson JE , Adami HO , Andersson S-O , Bergstrom R , Holmberg L , Krusemo UB . High 10-year survival rate in patients with early untreated prostate cancer. JAMA 1992; 267: 2191–6.

Chodak GW , Thisted RA , Gerber GS , Johanssen JE , Adolffson J , Jones GW . Results of conservative management of localised prostate cancer. N Engl J Med 1994; 330: 242–8.

Albertsen PC , Fryback DG , Storer BE , Kolon TF , Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995; 274: 626–31.

Aus G , Hugosson J , Norlen L. Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 1995; 154: 460–6.

Humphrey PA , Keetch DW , Smith DS , Shepherd DL , Catalona WJ . Prospective characterisation of pathological features of prostate carcinomas detected via serum prostate specific antigen screening. J Urol 1996; 155: 816–20.

Lerner SE , Blute ML , Bergstralh EJ , Bostwick DG , Eickholt JT , Zincke H. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 1996; 156: 137–43.

Epstein JL , Carmichael M , Partin WA , Walsh PCI . Is tumour volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993; 149: 1478–81.

Connolly JA , Shinohara K , Presti J.C. Jr. . Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 1996; 47: 225–31.

Gerber GS , Thisted RA , Scardino PT , Hubert GW , Frohmuller MD , Schroeder FH . Results of radical prostatectomy in men with clinically localised prostate cancer. Multi-institutional pooled analysis. JAMA 1996; 276: 615–19.

Zincke H , Bergstralh EJ , Blute ML , Myers RP , Barrett DM , Lieber MM , Martin SK , Oesterling JE . Radical prostatectomy for clinically localised prostate cancer: Long term results of 1143 patients from a single institution. J Clin Oncol 1994: 1994: 2254–64.

Stamey TA , Villers AA , McNeal JE , Link PC , Freiha FS . Positive surgical margins at radical prostatectomy: Importance of the apical dissection. J Urol 1990; 143: 1166–72.

Rosen MA , Goldstone L , Lapin S , Wheeler T , Scardino PT . Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol 1992; 148: 331–7.

Ohori M , Wheeler TM , Kattan MW , Goto Y , Scardino PT . Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995; 154: 1818–24.

Labrie F , Cusan L , Gomez JL , Diamond P , Suburu R , Lemay M. Downstaging of early stage prostate cancer before radical prostatectomy. The first randomised trial of neoadjuvant combination therapy with flutamide, and a luteinizing hormone-releasing hormone agonist. Urology 1994; 44(suppl): 29–37.

Van Poppel H , De Ridder D , Elgamal AA , Van de Voorde W , Werbrouck P , Ackaert K. Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer; Interim results of a prospective randomised trial. U Urol 1995; 154: 429–39.

Hanks GE , Diamond JJ , Krall JM , Martz KL , Kramer S. A ten year followup of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiation Oncol Biol Phys 1987; 13: 499–505.

Crook JM , Bahadur YA , Bociek RG , Perry GA , Robertson SJ , Esche BA . Radiotherapy for localised prostate carcinoma. Cancer 1997; 79: 328–36.

Pisanski TM , Kahn MJ , Rasp GM , Cha SS , Haddock MG , Bostwick DG . A multiple prognostic index predictive of disease outcome after irradiation for clinically localised prostate cancer. Cancer 1997; 79: 337–44.

Powell CR , Huisman TK , Riffenburgh RH , Saunders EL , Bethel KJ , Johnstone PAS . Outcome for surgically staged localised prostate cancer treated with external beam radiation therapy. J Urol 1997; 157: 1754–9.

Jonler M , Messing EM , Rhodes SR , Bruskewitz RC . Sequelae of radical prostatectomy. Br J Urol 1994; 74: 352–8.

Dillioglugil O , Leibman BD , Leibman NS , Kattan MW , Rosas AL , Scardino PT . Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 1997; 157: 1760–7.

Davidson PJT , van den Ouden D , Schroeder FH . Radical prostatectomy: Prospective assessment of mortality and morbiditv. Eur Urol 1996; 29: 168–73.

Walsh PC , Partin AW , Epstein JL . Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years. J Urol 1994; 152: 1831–6.

Hautmann RE , Sauter TW , Wenderoth UK . Radical retropubic prostatectomy: Morbidity and urinary incontinence in 418 consecutive cases. Urology 1994; 43: 47–51.

Feneley MR , Gillatt DA , Hehir M , Kirby RS . A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome. Br J Urol 1996; 78: 911–20.

Fowler F.J. Jr. , Barry MJ , Lu-Yao G , Wennberg JE . Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988–90. Urology 1993; 42: 622–9.

Quinlan DM , Epstein JI , Carter BS , Walsh PC . Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles. J Urol 1991; 145: 998–1002.

Aus G , Hugosson J , Norlen L. Need for hospital care and palliative treatment for prostate cancer treated with non curative intent. J Urol 1995; 154: 466–9.

Fransson P , Widmark A. Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Cancer 1996; 78: 1066–78.